A newly formed Baltimore company has raised $110 million to develop and commercialize a cancer-detecting blood test, created by Johns Hopkins researchers, that doctors would give patients during routine physicals.
Trending:
Baltimore firm raises $110 million to bring Johns Hopkins' cancer-detecting blood test to market